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Abstract
Background: Heterogeneity in patients with low back pain is well recognised and different approaches to subgrouping
have been proposed. One statistical technique that is increasingly being used is Latent Class Analysis as it performs
subgrouping based on pattern recognition with high accuracy. Previously, we developed two novel suggestions for
subgrouping patients with low back pain based on Latent Class Analysis of patient baseline characteristics (patient history
and physical examination), which resulted in 7 subgroups when using a single-stage analysis, and 9 subgroups when
using a two-stage approach. However, their prognostic capacity was unexplored. This study (i) determined whether the
subgrouping approaches were associated with the future outcomes of pain intensity, pain frequency and disability, (ii)
assessed whether one of these two approaches was more strongly or more consistently associated with these outcomes,
and (iii) assessed the performance of the novel subgroupings as compared to the following variables: two existing
subgrouping tools (STarT Back Tool and Quebec Task Force classification), four baseline characteristics and a group of
previously identified domain-specific patient categorisations (collectively, the ‘comparator variables’).
Methods: This was a longitudinal cohort study of 928 patients consulting for low back pain in primary care. The associations
between each subgroup approach and outcomes at 2 weeks, 3 and 12 months, and with weekly SMS responses were
tested in linear regression models, and their prognostic capacity (variance explained) was compared to that of the
comparator variables listed above.
Results: The two previously identified subgroupings were similarly associated with all outcomes. The prognostic capacity
of both subgroupings was better than that of the comparator variables, except for participants’ recovery beliefs and the
domain-specific categorisations, but was still limited. The explained variance ranged from 4.3%–6.9% for pain intensity
and from 6.8%–20.3% for disability, and highest at the 2 weeks follow-up.
Conclusions: Latent Class-derived subgroups provided additional prognostic information when compared to a range
of variables, but the improvements were not substantial enough to warrant further development into a new
prognostic tool. Further research could investigate if these novel subgrouping approaches may help to improve
existing tools that subgroup low back pain patients.
Keywords: Low back pain, Subgrouping, Classification, prognosis, Prospective studies, Latent class analysis
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Background
Low back pain (LBP) is highly prevalent and has several
negative consequences for society and individual patients
[1, 2]. In order to increase understanding of this health
condition, to enable better estimates of prognosis, and to
better match treatment to relevant characteristics of the
patients, several studies of various approaches to sub-
grouping (or classification) have been conducted [3–8].
However, much of the heterogeneity in LBP patients
remains poorly understood [9].
Many of the existing subgrouping approaches for use in
primary care have been developed using a quite narrow
spectrum of patient characteristics [10–16], for example,
the Quebec Task Force classification, which represents dif-
ferent degrees of back pain with or without the presence
of leg pain and signs of nerve root involvement [7]. This
classification is a diagnostic tool but has shown some pre-
dictive ability [17, 18]. Other subgrouping approaches have
included a broader spectrum of characteristics in their
subgroups, but aimed at identifying a specific number of
subgroups related to a particular treatment approach [3, 19,
20] or treatment need [5, 21]. For example, the STarT
Back Tool, which is a stratification tool for treatment
pathways, was developed using a method that drew upon
the domains of pain, participation, activity, psychology,
and the contextual factors of sex and age [5]. Its final form
is a 9-item questionnaire stratifying patients into three risk
groups of poor outcome from the current LBP episode,
based on factors from the domains of pain, activity and
psychology. The tool aims at improving health outcomes
and healthcare cost savings by targeting potentially modi-
fiable factors within each risk group [22].
These and other subgrouping approaches have increased
our understanding of LBP but their prognostic capacity is
still limited [23–26], and treatments based on subgroup-
ings have had small to moderate effects [10, 11, 13–15, 22,
27, 28]. Therefore, the investigation of new approaches to
subgrouping seems to have a merit.
One aspect to consider is that most previous subgroup-
ing approaches have used traditional regression modelling
techniques in which the multivariable relationships be-
tween the included variables are assumed to be the same
for all people in the sample. However, one of the theories
underlying subgrouping is that these multivariable rela-
tionships might vary, with one subgroup having one set of
relationships between these variables and another sub-
group having a different set of multivariable relationships.
For example, hypothetically there may be a strong rela-
tionship in one subgroup between fear of movement and
activity limitation, whereas this relationship may be weak
or absent in another subgroup with different patient
characteristics. It is likely that the essential information
about prognosis and response to treatment does not lie
in single variables but in certain scoring patterns across
several variables, and also possible that these scoring
patterns may differ across subgroups of patients. The
identification of such subgroups may be a key to a bet-
ter understanding and management of LBP patients.
Classifying the population of LBP patients into such
subgroups may also address the issue that the relation-
ship between the outcome and some baseline variables
may differ dependent on other baseline variables and
that subgroup membership may be one of those vari-
ables [29].
A recent study [30] attempted to address these issues
using Latent Class Analysis (LCA), as LCA allows explor-
ation of how multidimensional baseline variables might
form distinct patient subgroups when these are not
assumed to be related to each other in the same way in all
patients [31]. In that study, 112 baseline characteristics
covering aspects of activity, contextual factors (such as
sex, age, educational level and comorbidity), pain, partici-
pation, physical impairment and psychology were used in
a LCA to identify subgroups of patients. One subgrouping
was formed using a traditional single-stage approach to
LCA, where all baseline variables were included simultan-
eously in the subgrouping analysis. The other subgrouping
was formed from a two-stage approach, where the base-
line variables were descriptively classified into six health
domains, then participants were initially subgrouped by
LCA within each of these domains to identify ‘domain-
specific patient categorisations’ [32] and, subsequently
these subgroup memberships were used in a second LCA
to identify subgroups across domains [33, 34]. The use of
health domains was an attempt to potentially increase the
interpretability of the identified subgroups [33]. In both
LCA approaches, clinical interpretable subgroups which
differed on several baseline features were identified, but
neither approach (single-stage or two-stage) was judged
superior to the other based on statistical measures and
face validity.
So, this study explored whether these two novel sub-
grouping approaches have any clinical significant differ-
ence in their capacity for improving prognostic estimates,
as a mechanism to determine whether this aspect of exter-
nal validity differed between the two subgrouping ap-
proaches. Therefore, the aim of this paper was to (i)
determine whether membership in these previously identi-
fied subgroups was associated with outcomes of pain
intensity, pain frequency and disability over the 12 months
after the baseline consultation, (ii) assess whether one of
these two subgroup models was more strongly and/or
consistently associated with these outcomes, and (iii)
assess the prognostic performance of these novel models
compared to two existing subgrouping tools, four baseline
characteristics that are known to have some prognostic
capacity and to previously identified domain-specific
patient categorisations.
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Methods
Design and setting
This study used data from a prospective observational
cohort study which included adult patients with LBP who
had consulted one of 17 chiropractic clinics in the research
network of the Nordic Institute for Chiropractic and Clin-
ical Biomechanics in Denmark between September 2010 to
January 2012. The patients were followed for 1 year during
which interventions were not influenced by participation
in the study. Further information about the cohort study
has been reported previously [35–37]. Consenting partici-
pants with data on both patient self-reported and clinician-
reported baseline questionnaires were included in the
current study and their follow-up data, based on self-
reported questionnaires (2 weeks, 3 and 12 months) and
weekly Short Message Service (SMS) cell phone questions
over 12 months, were used as measures of patient
outcomes.
Study population
Included patients had a main complaint of LBP with or
without leg pain, were between 18 and 65 years old,
could adequately read and write Danish, had a mobile
phone and were able to send a text message. The pa-
tients were included regardless of the duration of their
LBP episode as our pragmatic interest was in subgroups
that could be found within the broad spectrum of cases
that present in primary care and because episode dur-
ation was one of the inputs to the LCA it could influ-
ence subgroup formation. Prospective participants were
excluded if they were pregnant, had serious pathology
including pathology of the back that necessitated referral
for acute surgical assessment or had attended more than
one consultation for LBP in the preceding 3 months.
The latter was to establish a cohort of patients who were
included at the time point when first seeking care for an
episode of LBP.
In total, 947 patients fulfilled the inclusion criteria and
provided written consent. For 928 of those, both the pa-
tient- and clinician-reported questionnaires were com-
pleted at baseline, and therefore they were included in
the current study. The available sample size was not
based on the requirements of the current study, but was
nonetheless adequate for applying regression models to
test the statistical association between an outcome and
many independent variables simultaneously, using the
typical rule-of-thumb that a minimum of ten partici-
pants per independent variable is required or other re-
lated rules [38].
Participation in this study did not affect treatment and
accordingly under Danish law, no ethical approval was
needed [39]. Approval was obtained from the Danish
Data Protection Agency (ref. no. 2012–41-0762).
Comparator prognostic variables
Subgroupings derived by latent class analysis
The main focus in this study was the subgroup member-
ship in the two subgroupings previously identified by
way of two separately conducted LCAs [30], one using a
traditional single stage approach and another using a two-
stage approach [33, 34]. No imputations were performed
during the subgrouping analyses, as LCA uses a likelihood
approach which accommodates the inclusion of patients
with missing values. In the previous study, the single-stage
LCA approach included 112 baseline characteristics that
were modelled simultaneously to identify ‘single-stage
subgroups’. In the two-stage LCA approach, the 112 base-
line characteristics were classified into six mutually exclu-
sive health domains that were used initially to identify
‘domain-specific patient categorisations’ (first stage LCA)
and these were then used as the input to a second stage
LCA that finally identified ‘two-stage subgroups’ across
domains. This resulted in seven single-stage subgroups
and nine two-stage subgroups. The selection of the pre-
ferred subgroup solutions for each LCA approach had
been informed by both statistical performance measures
and a qualitative evaluation of clinical interpretability (face
validity) [30]. The qualitative evaluation emphasised differ-
ences between the subgroups that were not only on a con-
tinuum of severity, but distinct differences in scoring
patterns across the baseline characteristic. For example, a
qualitative difference of two subgroups displaying opposite
scoring patterns on the same variables. Using this ap-
proach, potentially novel relationships between the base-
line characteristics were more likely to be identified. A
brief description of each subgroup is presented in Table 1
and a thorough description was previously published [30].
Within the analyses in this paper, each subgroup solution
was used as a categorical variable. The chosen order of the
categories was based on severity level as determined by the
baseline description of each subgroup. All authors contrib-
uted to this process and the final order was reached by
consensus.
In this paper, the six independent domain-specific pa-
tient categorisations (from the first stage of the two-stage
approach) were also used (See Additional file 1: Table A1).
The derivation of four of these categorisations has been
reported in another study that compared different LCA
strategies for using questionnaire data [32].
Baseline characteristics included in the comparison of
prognostic capacity
Two other subgrouping systems were used as examples of
the prognostic capacity of existing subgroupings. One was
the STarT Back Tool (SBT), which has three subgroups
that are based on patients’ risk of persistent LBP disability
(low, medium, high risk subgroups) calculated from a
patient self-reported questionnaire [5, 22, 40]. The other
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was the Quebec Task Force classification (local LBP only,
LBP + leg pain above the knee, LBP + leg pain below the
knee, and LBP + leg pain and neurological signs) repre-
senting a simple measure based on the clinician’s clinical
assessment [7, 17].
Four simple and commonly used baseline variables
known to have some prognostic capacity were also used
for the comparisons of prognostic capacity. These were:
typical LBP and typical leg pain intensity during the pre-
ceding week measured by 0 to 10 Numeric Rating Scales
[41, 42], the Danish 23 item version of the Roland-Morris
Disability Questionnaire (RMDQ-23) used as a measure of
pain-related disability that was proportionally recalculated
to a 0–100 score where 0 corresponding to ‘no disability’
and 100 ‘highest disability’ [43, 44], and participants’
recovery belief measured by a Numeric Rating Scale with
0 equalling ‘not at all likely to recover’ and 10 ‘very likely
to recover’ [37, 45].
Outcome measures
Two outcomes at 2 weeks, 3 and 12 months were col-
lected by post using patient self-completed questionnaires:
LBP intensity (typical LBP the last week, 0–10 Numeric
Rating Scale) and pain-related disability (the proportion-
ally recalculated score from the RMDQ-23). Three other
outcome measures were collected via weekly responses
over 12 months using automated SMS, with participants
replying with a number to each of the following questions
1) days with LBP the last week (0–7), 2) typical pain inten-
sity the last week (0–10) and, 3) days with activity limita-
tion the last week (0–7) [46, 47]. The second and third
questions were sent if the participants replied with other
than a zero to the first question.
Data analysis
In the descriptive analysis, nominal scale variables were
presented as proportions and continuous scale variables
as medians and their interquartile range. Baseline com-
parisons between the single-stage and two-stage LCA
subgroups, between responders and non-responders at
the three follow-up time points, as well as comparisons
between compliant SMS responders (less than 10 miss-
ing weeks of SMS replies [47]) and non-compliant re-
sponders, were tested using χ2 test for nominal variables,
and Kruskal-Wallis equality-of-populations rank test and
Wilcoxon rank-sum test (Mann–Whitney U test) for or-
dinal and continuous variables in relation to subgroups
and responders, respectively.
Association with outcome
The distribution of scores from each subgroup at every
follow-up time point were visualised and graphically
compared using stacked bar charts (pain intensity) and
box plots (disability). Linear regression modelling with
Table 1 Prevalence of Latent Class Analysis derived subgroups
Prevalence, N
Single-stage subgroups N = 928
SS1: Mildly affected: mild intermittent LBP (mild) 154 (17%)
SS2: Recent onset severe LBP, activity limitations (recent disability) 192 (21%)
SS3: Pain- and work-related concerns, high physical workload (work-related) 130 (14%)
SS4: Nerve root involvement (nerve root) 75 (8%)
SS5: Severely affected: very recent onset severe LBP, social participation and activity limitations (very recent) 136 (15%)
SS6: Persistent LBP, psychological issues, activity limitations and comorbidity (persistent) 132 (14%)
SS7: Severely affected: recent onset LBP with several consequences (severe) 109 (12%)
Two-stage subgroups N = 928
TS1: Mildly affected: mild intermittent LBP, moderate activity limitations, no participation limitations
(low degree of physical workload) (mild)
161 (17%)
TS2: Mildly affected: mild intermittent LBP with work-issues, no activity limitations, males (mild, work issues) 74 (8%)
TS3: Mildly affected: mild intermittent LBP, sleeps well, moderate activity limitations and sacroiliac joint pain, more females
(mild, sleep well)
69 (7%)
TS4: Mildly affected: persistent LBP with sacroiliac joint pain (mild persistent) 45 (5%)
TS5: Recent onset severe LBP, activity limitations, sleep issues (sleep issues) 113 (12%)
TS6: Work-related severe LBP (work-related) 127 (14%)
TS7: Nerve root involvement (nerve root) 49 (5%)
TS8: Severely affected: very recent onset severe LBP, social participation and activity limitations (very recent) 219 (24%)
TS9: Severely affected: LBP with several consequences (severe) 71 (8%)
LBP low back pain
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robust variance estimations was used to analyse if the sub-
groups were significantly associated with the outcome
measures at 2 weeks, 3 months and 12 months follow-
ups. In addition, illustrations of course trajectories that
showed the mean score per week over 12 months for each
subgroup were visually compared between the subgroups
for each of the three SMS outcome measures.
The significance of the differences between subgroups
were assessed by a longitudinal linear regression model
with the time in weeks as well as the subgroups as cat-
egorical covariates, taking the within-patient clustering
(due to 52 weekly SMS responses being modelled for
each patient) into account by using robust variance esti-
mation to compute p-values. No pairwise comparison
were performed. The visually observed differences be-
tween the mean trajectories were summarized across the
three outcomes verbally.
Prognostic capacity
Prognostic capacity was measured by the amount of vari-
ance explained in outcomes and quantified by the adjusted
R2 obtained in linear regression models, which was used
for comparisons between the LCA-derived subgroupings
and the previously described baseline characteristics. In
addition, we considered the adjusted R2 from a regression
model that included the six domain-specific patient cate-
gorisations as categorical covariates: this way we could as-
sess whether we lost prognostic information in the second
stage of the two-stage approach.
To explore if the LCA-derived subgroupings added
prognostic capacity to that of the baseline values of the
outcome measures of pain intensity and disability, or to
that of participants’ recovery beliefs, we used linear re-
gression models to calculate the difference in adjusted
R2 obtained from models including only these baseline
variables, and models in which the subgrouping variable
was added. Although the inclusion of the baseline values
is conceptually the same as analysing change scores, we
chose to include the baseline values as these are avail-
able for the clinician when considering the prognosis of
the individual patients, and change scores are unknown.
Lastly, we calculated the additional prognostic capacity
after taking into account both the baseline value of the
respective outcome variables and the participants’ recov-
ery beliefs. Again, for each of the investigated models,
the added prognostic capacity of the LCA-derived sub-
groupings was compared to that of the two other sub-
grouping tools, the remaining baseline variables and the
domain-specific patient categorisations.
All subgroup types (single-stage subgroups, two-stage
subgroups, SBT, Quebec classification and domain-
specific patient categorisations) were entered as categor-
ical variables in the regression analysis. The four simple
baseline variables were entered as continuous variables. In
all tests of associations, a P value <.05 was considered
significant.
Statistical software
All analyses were performed using STATA/IC 14.1
(StataCorp LP, College Station, TX, USA).
Results
Females were 45% of the participants, the mean age was
43 and the most common duration of LBP before consult-
ing the chiropractor was 2 weeks or less (62%) (Table 2).
On all of the tested baseline characteristics, significant dif-
ferences were found between the subgroups derived from
the single-stage, as well as between those derived using
the two-stage approach (See Additional file 1: Table A2a,
for the baseline characteristics of the single-stage sub-
groups and Table A2b for the baseline characteristics of
the two-stage subgroups). The differences were typically
small to moderate in size, except of those which you
would expect based on the definition of the groups. For
example, the median leg pain intensity ranged from 0 to 2
across most subgroups but was higher in subgroups de-
fined by nerve root involvement (subgroups SS4 and TS7,
median = 6) and in the most severe subgroups with
several consequences (SS7 and TS9, median = 4 and 3,
respectively).
Response rates
The response rates to the follow-up questionnaires varied
across outcomes and follow-up time points with the low-
est rates on any outcome being 67% at 2 weeks, 79% at
3 months and 73% at 12 months. Baseline differences
between responders and non-responders were similar
across outcomes and time points with non-responders
being younger, more often males and having slightly lower
recovery beliefs (See Additional file 1: Table A3 which pre-
sents the comparisons between responders and non-
responders). For example, for the outcome of disability at
12 months follow-up, non-responders were younger
[39 years versus 45 years, P < .01]; more often male [62%
versus 53%, P = .01], and had slightly lower recovery be-
liefs [median 9 {IQR 5–10} versus median 9 {IQR 7–10},
P = .01]. Within each of the single-stage and two-stage ap-
proaches, the response rates differed between subgroups
at 12 months for the questionnaire outcomes of LBP in-
tensity and disability, with non-responders being slightly
overrepresented in the following single-stage subgroups:
SS3 (work-related), SS6 (persistent) and SS7 (severe), and
two-stage subgroups: TS6 (work-related), TS7 (nerve
root), TS8 (very recent) and TS9 (severe).
There was a high response rate across the whole year
to the SMS questions with 80% of individuals having less
than 10 weeks with missing SMSs (compliant re-
sponders), and 76% of the participants responded to the
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SMS questions in all of the last 3 weeks (week 50 to
week 52). The baseline differences between the compli-
ant and non-compliant SMS responders were similar
across the three SMS questions (See Additional file 1:
Table A4, which presents the comparisons between
compliant responders and non-compliant responders).
For the outcome of LBP intensity, the non-compliant
responders were underrepresented in the SBT low risk
group (45% versus 56%, P = .01), had a slightly higher
baseline leg pain intensity (2 versus 1, P = .07) and
slightly lower recovery beliefs (median 9 [IQR 5–10] ver-
sus median 9 [IQR 7–10], P = .08). Only the single-stage
subgroups differed statistically in their response rates
with non-compliant responders being slightly underrep-
resented in the SS2 (recent disability) and SS4 (nerve
root) subgroups.
Associations between the single-stage subgroups and
outcomes
Pain intensity
There was a statistically significant association between
single-stage subgroups and pain at all three outcome
time points (Table 3). Generally, the patients in sub-
groups SS1 (mild), SS2 (recent disability) and SS5 (very
recent) had the best outcome in terms of reporting low
absolute pain scores over time, the patients in subgroups
SS6 (persistent) and SS7 (severe) reported the worst out-
come, and SS3 (work-related) and SS4 (nerve root)
patients had intermediate pain scores (Fig. 1).
Trajectories
For all three types of outcome trajectories (pain inten-
sity, pain frequency, and disability frequency) we found
statistically significant differences between the single-
stage subgroups and the outcome (p < 0.001). The pa-
tients in subgroups SS1 (mild), SS2 (recent disability)
and SS5 (very recent) had the mildest trajectories across
these SMS outcomes and the SS3 (work-related) patients
differed from them by having had a higher intensity and
frequency of LBP. The patients in subgroups SS4 (nerve
root), SS6 (persistent) and SS7 (severe) had the most
severe trajectories although SS4 (nerve root) patients
reported slightly less intense LBP than the other two
subgroups (Fig. 2).
Disability
Statistically significant associations were found between
the single-stage subgroups and disability at all three
follow-up time points (Table 3). Generally, SS1 (mild),
SS2 (recent disability), SS3 (work-related) and SS5 (very
recent) patients had the lowest disability scores, followed
by SS4 (nerve root) and SS6 (persistent) patients. The
SS7 (severe) patients reported the highest disability
score, however they experienced a slower but eventually
better recovery compared to SS4 (nerve root) and SS6
(persistent) patients (Fig. 3).
Across all outcomes the general order of the sub-
groups on outcome severity was SS1 (mild), SS2 (recent
disability), SS5 (very recent), SS3 (work-related), SS4
(nerve root), SS6 (persistent) and SS7 (severe).
Table 2 Baseline characteristics of the low back pain cohort
Low back
pain patients
N = 928
Males, N 510 (55%)
Age in years, median (interquartile range) 43 (34–53)
Highest achieved education, N
No qualification 81 (9%)
Vocational training 236 (25%)
Higher education <3 years 142 (15%)
Higher education 3–4 years 311 (34%)
Higher education >4 years 136 (15%)
Missing 22 (2%)
Episode duration, N
0–2 weeks 571 (62%)
2–4 weeks 123 (13%)
1–3 months 95 (10%)
> 3 months 121 (13%)
Missing 18 (2%)
Back pain intensity (0–10 Numeric Rating Scale),
median (interquartile range)
7 (5–8)
Missing, N 25 (3%)
Leg pain intensity (0–10 Numeric Rating Scale),
median (interquartile range)
2 (0–4)
Missing, N 43 (5%)
STarT Back Tool score, N
Low risk 497 (54%)
Medium risk 351 (38%)
High risk 72 (8%)
Missing 8 (1%)
Quebec classification, N
Local low back pain only 609 (66%)
Low back pain + leg pain above the knee 218 (23%)
Low back pain + leg pain below the knee 69 (7%)
Low back pain + leg pain and neurological signs 20 (2%)
Missing, N 12 (1%)
Roland-Morris Disability Questionnaire, proportionally
recalculated score (0–100 = highest disability),
median (interquartile range)
52 (35–70)
Missing, N 14 (2%)
Recovery belief (0–10 = very likely), median
(interquartile range)
9 (7–10)
Missing, N 13 (1%)
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Fig. 1 Pain intensity for the two subgrouping approaches. SS = single-stage subgroups; TS = two-stage subgroups. Proportion of patients reporting
each level of typical LBP intensity within the last week (0–10) at 2-weeks, 3-months and 12-months follow-up
Fig. 2 Trajectories based on weekly SMS questions over 12 months for the single-stage subgroups. SMS: Short Message Service; LBP = low back
pain; SS = single-stage subgroups; p-values indicate a statistical significant difference between the subgroups for that outcome
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Associations between the two-stage subgroups and
outcomes
Pain intensity
There was a statistically significant association between the
two-stage subgroups and pain intensity at all three out-
come time points (Table 3). Overall, TS1 (mild) patients
had the lowest pain intensity score and TS7 (nerve root)
and TS9 (severe) patients had the highest pain intensity
score. The patients in the remaining subgroups had inter-
mediate pain scores and differed only slightly, such as TS4
(persistent) patients having the slowest recovery rate and
TS8 (very recent) patients having the fastest recovery, com-
pared to the others (Fig. 1).
Trajectories
For all three types of outcome trajectories (pain inten-
sity, pain frequency, and disability frequency) we found
statistically significant differences between the two-stage
subgroups and the outcome (p < 0.001). Generally, TS1
(mild) patients had the mildest trajectory across SMS
outcomes and TS2 (mild, work issues), TS3 (mild, sleep
well), TS5 (sleep issues), TS6 (work-related) and TS8
(very recent) patients differed from those in TS1 (mild)
by having a slightly higher pain intensity and frequency.
The TS7 (nerve root) and TS9 (severe) patients had the
most severe pain intensity trajectories but differed from
each other as TS7 (nerve root) patients had a higher
frequency of days with activity limitation and pain. The
TS4 (mild persistent) patients differed from TS9 (severe)
patients by having slightly lower pain intensity and fewer
days with activity limitation (Fig. 4).
Disability
At all three follow-up time points, there was a statisti-
cally significant association between the two-stage sub-
groups and disability (Table 3). Broadly, the TS1 (mild)
patients had the lowest disability score at all follow-up
time points followed by TS2 (mild, work issues) and TS3
(mild, sleep well) patients. The patients in subgroups
TS5 (sleep issues), TS6 (work-related) and TS8 (very
recent) all mainly differed to TS2 (mild, work issues)
and TS3 (mild, sleep well) patients by having a bigger
decrease in disability over time, in part made possible by
their having a higher disability score at 2 weeks. The pa-
tients in subgroups TS7 (nerve root) and TS9 (severe)
had the highest disability scores overall. The TS4 (mild
persistent) patients had quite low disability scores and
the most consistent score over time (Fig. 3).
Across all outcomes, the general order of the sub-
groups on outcome severity was TS1 (mild), TS2 (mild,
work issues), TS3 (mild, sleep well), TS8 (very recent),
TS5 (sleep issues), TS6 (work-related), TS4 (mild persist-
ent), TS9 (severe) and TS7 (nerve root).
Prognostic capacity
An overview of the prognostic capacity of the subgroup-
ings compared to the prognostic variables used in this
study is presented in Table 4.
Fig. 3 Roland-Morris proportionally recalculated disability score for the two subgrouping approaches. SS = single-stage subgroups; TS = two-stage subgroups
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Prognostic capacity for absolute outcomes
At each follow-up, the prognostic capacity of the single-
stage and the two-stage subgroupings was similar on both
the outcomes of pain intensity and disability (Table 3).
Overall, the prognostic capacity of both subgroupings was
better than the SBT and Quebec classifications for pain
intensity as well as disability. This was the same, when
comparing the subgroupings to the baseline question
about disability, except for the prognostic capacity at 2
weeks being no better for the outcome of disability. The
single question about the participants’ recovery belief had
a higher prognostic capacity than both of the new sub-
groupings for pain intensity at 3 months and disability at
12 months, a similar prognostic capacity for pain intensity
at 2 weeks and 12 months and disability at 3 months, but
lower at 2 weeks for disability. The remaining baseline
characteristics had a lower prognostic capacity than both
of the new subgroupings for both outcomes and at all the
time points. Interestingly, the regression model that in-
cluded the six independent domain-specific patient cate-
gorisations (first stage of the two-stage approach) had a
distinctly higher prognostic capacity compared to all of
the other investigated prognostic models on both out-
comes and at all three time points.
Prognostic capacity in addition to the baseline values of the
outcome measures
As expected, the prognostic capacity ascribed to the sub-
groups decreased when including the baseline values of
the outcomes, and still there was no difference between
the two LCA approaches to subgrouping (Table 5).
Again, the prognostic capacity for both subgroupings
was better compared to SBT and Quebec classifications
for pain intensity, as well as for disability. However, in
this model the single question about baseline leg pain in-
tensity had similar prognostic capacity to the subgroup-
ings at 2 weeks and 12 months for the outcome of pain
intensity, but as in the previous model, a lower prognos-
tic capacity at 3 months and at all time points for the
outcome of disability. Similarly to the previous model,
both subgroupings had a distinctly higher prognostic
capacity at all time points, compared to the baseline
question of disability for the outcome of pain intensity.
This was the same when compared to the baseline ques-
tion of pain intensity for the outcome of disability. As
before, the single question about the participants’ recov-
ery belief had a somewhat higher prognostic capacity
than both of the new subgroupings for pain intensity at
3 months, and a similar prognostic capacity for pain in-
tensity at 2 weeks and 12 months, but a higher prognos-
tic capacity at both 3 and 12 months for the outcome of
disability. Again, the regression model that included the
six independent domain-specific patient categorisations
had a distinctly higher prognostic capacity compared to
all of the other investigated prognostic models on both
outcomes and at all three time points.
Prognostic capacity in addition to participants’ recovery
beliefs
Once again, the prognostic capacity of the new subgroup-
ings was very similar for both outcomes when added to
that of participants’ recovery beliefs (Table 6). Also, the
Fig. 4 Trajectories based on weekly SMS questions over 12 months for the two-stage subgroups. SMS: Short Message Service; LBP = low back pain;
TS = two-stage subgroups; p-values indicate a statistical significant difference between the subgroups for that outcome
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prognostic capacity for both subgroupings was better com-
pared to both the SBT and Quebec classifications for pain
intensity as well as disability, with the exception that the
Quebec classification was similar to both subgroupings for
pain intensity at 3 months. Again, both subgroupings at all
time points and for both outcomes had a higher prognostic
capacity than that of baseline back pain intensity. Also, the
single question about baseline leg pain intensity had similar
prognostic capacity to that of the subgroupings on the out-
comes of pain intensity at 2 weeks and 12 months, but also
for disability at 12 months, and a lower prognostic capacity
at other time points. For the outcome of pain intensity, the
prognostic capacity of the subgroupings was better than
that of the baseline disability question at all time points,
but for the outcome of disability, the prognostic capacity of
the subgroupings was better at 3 months, similar at
12 months and lower at 2 weeks. As before, the regression
model including the six independent domain-specific pa-
tient categorisations (first stage of the two-stage approach)
had a distinctly higher prognostic capacity than all the
other investigated prognostic models on both outcomes
and at all three time points.
Prognostic capacity in addition to the baseline values of the
outcomes and participants’ recovery beliefs
Here also, there was no difference in prognostic capacity
of the new subgroupings for the outcomes of pain inten-
sity and disability when taking into account both the base-
line values of these outcomes and participants’ recovery
beliefs (Table 7). Again, a better prognostic capacity were
seen for both subgroupings when compared to that of
SBT and Quebec classification for pain intensity as well as
disability, with the exception that the Quebec classifica-
tion was similar to both subgroupings for pain intensity at
3 months but, in this case, also for disability at 12 months.
As before, both subgroupings and at all time points,
had a distinctly higher prognostic capacity when com-
pared to the baseline question of disability for the out-
come of pain intensity, and compared to the baseline
question of pain intensity for the outcome of disability.
In this model, the baseline leg pain intensity question
had a slightly higher prognostic capacity compared to
the subgroupings for pain intensity at 2 weeks and
12 months, and for disability at 12 months, but as be-
fore, a lower prognostic capacity at other time points.
Once again, the regression model that included the six
independent domain-specific patient categorisations
(first stage of the two-stage approach) had a distinctly
higher prognostic capacity compared to all the other
investigated prognostic models on both outcomes and
at all three time points.
An overview of the process and final results are shown
in Fig. 5.
Discussion
This study investigated the prognostic capacity of two
novel LCA-derived subgroupings of patients with LBP.
Neither of these LCA approaches were judged to have a
better prognostic capacity then the other, as the single-
stage and the two-stage subgroupings were similarly as-
sociated with the questionnaire-based outcomes of pain
intensity and disability at 2 weeks, 3 and 12 months, and
were similarly associated with the weekly SMS-collected
outcomes of pain intensity, pain frequency and disability
over 12 months. Their prognostic capacity was similar
to, or somewhat better, than the two existing subgroup-
ing tools that were included for comparison in this study
for the outcome measures of pain intensity and disabil-
ity. Their prognostic capacity was also similar to, or
somewhat better than, the prognostic capacity of base-
line LBP intensity and disability. These two novel sub-
groupings generally had a higher prognostic capacity
than that of the baseline leg pain intensity for the out-
come of disability, but not consistently so for the out-
come of pain intensity. Compared to participants’
recovery beliefs, the subgroupings had a lower prognos-
tic capacity for the outcome of pain intensity at 3 months
and for the outcome of disability at 12 months, and simi-
lar prognostic capacity for the outcome pain intensity at
2 weeks and 12 months and for the outcome of disability
at 3 months. These novel subgroupings also had a lower
prognostic capacity than that of the domain-specific
patient categorisations formed in the first stage of the
two-stage LCA approach. The prognostic capacity of these
two novel subgroupings was limited in size for the out-
come of pain intensity (adjusted R2 ranging from 4.3% to
6.9%), but more substantial for the outcome of disability
(6.8% to 20.3%), and highest at the first follow-up time
point. The subgroupings did not provide substantial add-
itional prognostic information when added to regression
models that included the baseline values of participants’
recovery beliefs and either pain or disability.
Association between the subgroups and outcomes
On both the questionnaire and SMS based outcome mea-
sures, the subgroups generally showed the same order of
outcome severity and differed statistically on all outcome
measures, albeit that the differences between some of the
subgroups were small, especially at 3 and 12 months.
Characteristics of subgroups with the least and most severe
outcome levels
To understand the relationship between baseline charac-
teristics and outcomes, it can be helpful to consider these
subgroups relative to the least and most severe outcome
levels. Subgroups showing the lowest severity level over
time were either mildly affected at baseline regardless of
the duration of their LBP or were severely affected at
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baseline but with recent onset. In addition, they differed
on work-issues, sleep-issues, degree of activity limitation
and sacroiliac joint pain. However, one exception was the
subgroup TS4 (mild persistent) whose members were also
mildly affected at baseline, but differed from the others as
they had a high severity level over time. Patients in this
subgroup, and the subgroups that were severely affected
at baseline, differed qualitatively on the degree of nerve
root involvement, psychological issues and persistence of
their LBP. This aligns with previous evidence for markers
of a poor prognosis [17, 40, 48]. It also suggests a need to
differentiate between potential causes of poor outcome ra-
ther than simply summing prognostic factors into one
prognostic sum score (‘vote counting’). For example, the
prognostic capacity of leg pain has been questioned, as
this might be explained by other concurrent baseline char-
acteristics, such as differences in pain duration, LBP sever-
ity, demographic and psychological characteristics [49].
However, another explanation could be that the prognos-
tic capacity of leg pain depends on its relationship with
other baseline characteristics. In our study, the subgroups
with the most severe outcome level also included the lar-
gest proportion of patients with leg pain. However, while
for the subgroups characterised by nerve root
involvement (SS4 and TS7) leg pain seemed to inform the
subgrouping, in contrast, in the other subgroups charac-
terised by persistent LBP (SS6 and TS4) and severe LBP
(SS7 and TS9), it seemed to have less impact on the sub-
grouping. Therefore, other characteristics, or potentially a
group of characteristics, seem to have informed the sub-
grouping. So, despite similar outcome measures for the
most severe subgroups, these qualitative differences may
provide pointers towards ways in which these subgroups
could be managed and treated differently to obtain a
greater improvement. This deserves further investigation.
Prognostic capacity
The prognostic capacity of the two new subgroupings
were similar across time points and outcome measures,
and therefore neither of these subgroupings was more
Fig. 5 Overview of method and results. LBP = low back pain
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strongly or consistently associated with outcomes than the
other. However, the prognostic capacity of the new sub-
groupings was somewhat better than that of the two exist-
ing subgrouping tools used for comparison and therefore,
there seems to be potentially important information
within these new subgroups. This may be predictable,
given that the new subgroupings were based on the same
baseline characteristics covered by the existing subgroup-
ing tools, plus additional baseline information. However,
this indicates that additional prognostic information may
be derived from clusters of the variables that are tradition-
ally measured at an initial consultation for LBP.
Still, it remains unclear how we can best extract and
use this information. In particular, the domain-specific
patient categorisations from the first stage of the two-
stage approach showed a quite large prognostic capacity
when entered directly into regression models. This indi-
cates that the approach to aggregate information into a
simple subgrouping – as done by the two-stage approach
– is suboptimal with respect to the use of the available
information. However, the prediction rule based on using
the domain-specific categorisations as input would not
currently be directly applicable in practice. It would
require a determination of each patient’s assignment to a
subgroup within each domain and then to build a sum-
mary score model involving overall 37 weights. Hence,
there remains a task to find better and simpler ways to ag-
gregate these domain specific categorisations.
Strengths and limitations
One strength of this study was the use of multiple and
frequently used LBP outcome measures to test novel LCA-
derived subgroupings. Another strength was that the LCA-
derived subgroupings were formed in a large sample of LBP
patients and these subgroups were selected not only on
statistical criteria but also on their qualitative differences.
This allowed identification of otherwise unrecognised rela-
tionships between baseline characteristics and was used to
incorporate more of the clinical complexity of LBP into this
prognostic study. The extent to which the results of such
complex subgroupings can be generalised to other patient
populations is unknown and this should be investigated.
Comparing the prognostic capacity of our novel sub-
grouping approaches to two other subgrouping tools (one
based on patient-reported questionnaire responses and one
that included clinical examination findings), and other
known predictors, also strengthened our study. However, as
there is evidence that the predictive ability of the SBT is
stronger in populations with LBP of more than 2 weeks
duration [50], which was only 36% of this cohort, it is
unknown if the relative performance of these novel sub-
groupings would be different in other settings.
In addition, we recognise that neither the Quebec classifi-
cation nor the SBT are primarily designed to be prognostic
tools. However, the Quebec classifications, especially the
characteristics of pain localisation and neurological signs
have been shown to influence prognosis and therefore, the
use of the Quebec classification as a comparator was con-
sidered reasonable [18, 51]. The SBT was developed to
stratify treatment. If such stratified treatment had been
applied by the chiropractors, either consciously or subcon-
sciously, the prognostic value of the SBT could have been
reduced due to appropriate treatment matching resulting in
better patient outcomes in all risk groups. The same issue
may relate to the Quebec classification and the LCA de-
rived classifications if that somehow guided treatment deci-
sions. Therefore, the study might have been strengthened
had adjustment for any differences in the type of treatment
and the number of treatment sessions been performed as
the specific characteristics of each subgroup may have had
an influence on treatment decisions. Unfortunately, detailed
treatment information was not obtained in the original data
collection. As a result, we cannot rule out that the observed
outcome differences between subgroups are confounded
with treatment differences between subgroups, although we
know the participants received a quite homogeneous treat-
ment package by the chiropractors consisting of health
information, manual treatment and exercises. As always,
less loss to follow-up would have strengthened the study
and reduced any potential responder bias.
In evaluating the subgroupings derived from the LCA
approaches, we ignored that there may have been poten-
tial misclassification of some subjects, as we relied purely
on the highest posterior probability. Alternatively, we may
have used the posterior probabilities themselves as input
to the regression models (i.e. considered their prognostic
capacity) or may have used approaches to correct for bias
due to misclassification (BCH, [52, 53]). However, this
would not directly address the question about the prog-
nostic capacity of the subgroupings themselves.
In this paper, we did not address the clinically feasibility
of the subgroupings, e.g. whether they can be identified in
practice based only on the verbal description or whether
they can be implemented by using algorithmic support.
Taking the rather low prognostic capacity into account,
there is currently no merit for investigating this aspect.
However, the promising results when using the domain
specific categorisations and the role of single variables like
the patient’s recovery beliefs may pave a way to obtain clin-
ically feasible subgroupings or scoring rules in the future
based on our data.
Conclusions
Subgroups can have clinical significance if they predict bet-
ter response to more targeted treatment and/or if they
allow more precise estimates of prognosis. In this study, we
only investigated the prognostic implications of these novel
subgroups and found a relatively small amount of added
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prognostic capacity compared to simpler subgrouping tools.
Consequently, we do not currently see direct implications
of these LCA-derived subgroupings for clinical practice, in
particular as their complexity suggests that direct clinical
application would require software support. However, if
these novel subgroups were further investigated and found
to respond better to treatment that targets subgroup-
specific modifiable factors, then a clinical implication of
these subgroups may appear. Our current prognostic find-
ings do not justify developing these new subgroupings into
clinical prediction rules, especially when taking into ac-
count the comprehensive and time-consuming baseline
questionnaires that formed the subgroupings. However, fur-
ther research could aim at identifying the distinct character-
istics that carried additional prognostic capacity in order to
improve existing subgrouping tools and also investigate if
distinctive aspects of these subgroups might be suitable for
targeted treatment. Furthermore, the characteristics that
differentiated these subgroups could be investigated in a
causal model framework to determine whether they suggest
the existence of different casual pathways.
In addition, the lower prognostic capacity of the two-
stage subgrouping, compared to using domain-specific
patient categorisations, indicates that there is an infor-
mation loss going from the first to the second stage of
the two-stage LCA approach. This warrants further
methodological investigation from both a statistical and
a conceptual perspective.
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